相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia
Mohammad Faizan Zahid et al.
LEUKEMIA & LYMPHOMA (2017)
TET proteins regulate the lineage specification and TCR-mediated expansion of iNKT cells
Ageliki Tsagaratou et al.
NATURE IMMUNOLOGY (2017)
Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin
L. Brunetti et al.
LEUKEMIA (2017)
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Jose J. Fuster et al.
SCIENCE (2017)
Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia
Alyssa Carey et al.
CELL REPORTS (2017)
Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents
Ana Alfonso et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
Tetsuichi Yoshizato et al.
BLOOD (2017)
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
Theo de Witte et al.
BLOOD (2017)
Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases
Laura Palomo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Response to erythropoietic-stimulating agents in patients with chronic myelomonocytic leukemia
Blanca Xicoy et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Age-related mutations and chronic myelomonocytic leukemia
C. C. Mason et al.
LEUKEMIA (2016)
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
Chiara Elena et al.
BLOOD (2016)
When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia
Markus Ball et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001-12
Samer A. Srour et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)
Eric Padron et al.
CLINICAL CANCER RESEARCH (2016)
Clinical Prognostic Factors and Survival Outcome Of Chronic Myelomonocytic Leukemia: Reviewing 3,686 Patients
Mohamed Abd El-Fattah
Clinical Lymphoma Myeloma & Leukemia (2016)
Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale
Hanadi Ramadan et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
Control of Foxp3 stability through modulation of TET activity
Xiaojing Yue et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors
K. Geissler et al.
LEUKEMIA (2016)
Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?
Mette Vestergaard Elbaek et al.
LEUKEMIA & LYMPHOMA (2016)
Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia
Jean-Baptiste Fraison et al.
LEUKEMIA RESEARCH (2016)
Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review
Eric Grignano et al.
LEUKEMIA RESEARCH (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
Jane Merlevede et al.
NATURE COMMUNICATIONS (2016)
Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance
M. M. Patnaik et al.
BLOOD CANCER JOURNAL (2016)
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia
Dorothee Selimoglu-Buet et al.
BLOOD (2015)
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
Michael R. Savona et al.
BLOOD (2015)
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia
Kristen Meldi et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands
Avinash G. Dinmohamed et al.
LEUKEMIA RESEARCH (2015)
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome (vol 4, e270, 2015)
M. M. Patnaik et al.
BLOOD CANCER JOURNAL (2015)
An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
E. Padron et al.
BLOOD CANCER JOURNAL (2015)
Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study
Emnet A. Wassie et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
Luca Malcovati et al.
BLOOD (2014)
ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia
Eric Padron et al.
BLOOD (2014)
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
M. M. Patnaik et al.
LEUKEMIA (2014)
Hydroxymethylation at Gene Regulatory Regions Directs Stem/Early Progenitor Cell Commitment during Erythropoiesis
Jozef Madzo et al.
CELL REPORTS (2014)
Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components
Sa A. Wang et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
Eric Padron et al.
BLOOD (2013)
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
Koichi Takahashi et al.
BLOOD (2013)
Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
O. Kosmider et al.
LEUKEMIA (2013)
An evolutionary perspective on chronic myelomonocytic leukemia
R. Itzykson et al.
LEUKEMIA (2013)
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
F. Damm et al.
LEUKEMIA (2013)
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
M. M. Patnaik et al.
LEUKEMIA (2013)
Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine
Lionel Ades et al.
LEUKEMIA RESEARCH (2013)
Specific Skin Lesions in Chronic Myelomonocytic Leukemia A Spectrum of Myelomonocytic and Dendritic Cell Proliferations. A Study of 42 Cases
Franck Vitte et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
Manja Meggendorfer et al.
BLOOD (2012)
Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
Hans Carl Hasselbalch
BLOOD (2012)
Langerhans cell histiocytosis first presenting in the skin in adults: frequent association with a second haematological malignancy
J. R. Edelbroek et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
Thorsten Braun et al.
BLOOD (2011)
Cytogenetic risk stratification in chronic myelomonocytic leukemia
Esperanza Such et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance
V. Grossmann et al.
LEUKEMIA (2011)
Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia
Nathalie Droin et al.
BLOOD (2010)
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
Veronique Gelsi-Boyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Morphological evaluation of monocytes and their precursors
Jean E. Goasguen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux et al.
LANCET ONCOLOGY (2009)
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates
Nikesh Kotecha et al.
CANCER CELL (2008)
Hematopoietic progenitor cell colony growth differentiates chronic myelomonocytic leukemia from reactive monocytosis
Angelika Birrer et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Monocytosis is an adverse prognostic factor for survival in younger patients with primary myelofibrosis
M. A. Elliott et al.
LEUKEMIA RESEARCH (2007)
Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome
H Kantarjian et al.
CANCER (2006)
Risk assessment in chronic myelomonocytic leukemia (CMML)
U Germing et al.
LEUKEMIA & LYMPHOMA (2004)
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients
F Onida et al.
BLOOD (2002)
分享论文
